Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason P Connor

Showing results (51-60 of 171) with videos related to

Pageof 18
Sort By:
Journal of Addictive Diseases|November 8, 2006
Is acamprosate use in alcohol dependence treatment reflected in improved subjective health status outcomes beyond cognitive behavioural therapy alone?Gerald F X Feeney, Jason P Connor, Ross McD Young, et al.
Addictive Behaviors|July 12, 2016
Alcohol misuse in emerging adulthood: Association of dopamine and serotonin receptor genes with impulsivity-related cognitionTalia E Leamy, Jason P Connor, Joanne Voisey, et al.
Addiction (Abingdon, England)|June 3, 2026
Impact of bariatric surgery on alcohol-use disorder and alcohol-related liver disease: A retrospective studyThomas J Williams, Andrew J Palmer, Jason P Connor, et al.
Addictive Behaviors|August 8, 2021
Age-related trends in cannabis use in Australia. Findings from a series of large nationally representative surveysGary Chan, Vivian Chiu, Tianze Sun, et al.
Drug Safety|May 26, 2018
Prescription Opioid Fatalities: Examining Why the Healer Could be the CulpritAdeleke D Adewumi, Christine E Staatz, Samantha A Hollingworth, et al.
Drug and Alcohol Review|May 9, 2012
Evidence that community-based prevention reduces adolescent alcohol use: a commentary on Gilligan et alCaroline L Salom, April Holman, Jason P Connor, et al.
Addiction (Abingdon, England)|November 18, 2021
Clinical management of cannabis withdrawalJason P Connor, Daniel Stjepanović, Alan J Budney, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|February 10, 2006
Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapyGerald F X Feeney, Jason P Connor, Ross McD Young, et al.
CNS Drugs|March 3, 2018
Prescribed Dose of Opioids and Overdose: A Systematic Review and Meta-Analysis of Unintentional Prescription Opioid OverdoseAdeleke D Adewumi, Samantha A Hollingworth, Joemer C Maravilla, et al.
The Australian and New Zealand Journal of Psychiatry|September 17, 2004
Alcohol dependence: the impact of cognitive behaviour therapy with or without naltrexone on subjective health statusGerald F X Feeney, Jason P Connor, Ross Mc D Young, et al.
Pageof 18

Showing results (51-60 of 171) with videos related to

Sort By:
Pageof 18
Journal of Addictive Diseases|November 8, 2006
Is acamprosate use in alcohol dependence treatment reflected in improved subjective health status outcomes beyond cognitive behavioural therapy alone?Gerald F X Feeney, Jason P Connor, Ross McD Young, et al.
Addictive Behaviors|July 12, 2016
Alcohol misuse in emerging adulthood: Association of dopamine and serotonin receptor genes with impulsivity-related cognitionTalia E Leamy, Jason P Connor, Joanne Voisey, et al.
Addiction (Abingdon, England)|June 3, 2026
Impact of bariatric surgery on alcohol-use disorder and alcohol-related liver disease: A retrospective studyThomas J Williams, Andrew J Palmer, Jason P Connor, et al.
Addictive Behaviors|August 8, 2021
Age-related trends in cannabis use in Australia. Findings from a series of large nationally representative surveysGary Chan, Vivian Chiu, Tianze Sun, et al.
Drug Safety|May 26, 2018
Prescription Opioid Fatalities: Examining Why the Healer Could be the CulpritAdeleke D Adewumi, Christine E Staatz, Samantha A Hollingworth, et al.
Drug and Alcohol Review|May 9, 2012
Evidence that community-based prevention reduces adolescent alcohol use: a commentary on Gilligan et alCaroline L Salom, April Holman, Jason P Connor, et al.
Addiction (Abingdon, England)|November 18, 2021
Clinical management of cannabis withdrawalJason P Connor, Daniel Stjepanović, Alan J Budney, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|February 10, 2006
Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapyGerald F X Feeney, Jason P Connor, Ross McD Young, et al.
CNS Drugs|March 3, 2018
Prescribed Dose of Opioids and Overdose: A Systematic Review and Meta-Analysis of Unintentional Prescription Opioid OverdoseAdeleke D Adewumi, Samantha A Hollingworth, Joemer C Maravilla, et al.
The Australian and New Zealand Journal of Psychiatry|September 17, 2004
Alcohol dependence: the impact of cognitive behaviour therapy with or without naltrexone on subjective health statusGerald F X Feeney, Jason P Connor, Ross Mc D Young, et al.
Pageof 18